Eric Schaefer Net Worth

The estimated Net Worth of Eric Schaefer is at least $299 mil dollars as of 22 February 2021. Mr. Schaefer owns over 3,842 units of Pacific Biosciences of California Inc stock worth over $148,636 and over the last 4 years he sold PACB stock worth over $150,606. In addition, he makes $0 as Chief Accounting Officer y Vice President at Pacific Biosciences of California Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Schaefer PACB stock SEC Form 4 insiders trading

Eric has made over 1 trades of the Pacific Biosciences of California Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 3,842 units of PACB stock worth $150,606 on 22 February 2021.

The largest trade he's ever made was selling 3,842 units of Pacific Biosciences of California Inc stock on 22 February 2021 worth over $150,606. On average, Eric trades about 1,921 units every 0 days since 2021. As of 22 February 2021 he still owns at least 88,474 units of Pacific Biosciences of California Inc stock.

You can see the complete history of Mr. Schaefer stock trades at the bottom of the page.

Eric Schaefer biography

Eric E. Schaefer serves as Chief Accounting Officer, Vice President of the Company. He was previously the Company’s Senior Director, Corporate Controller since March 2019 and previously served as the Company’s Assistant Controller since June 2012. Prior to joining the Company, Mr. Schaefer served as an auditor at PricewaterhouseCoopers from 2005 to 2012, most recently as Audit Manager. Mr. Schaefer holds a B.S. in Accounting from Brigham Young University and is a certified public accountant.

How old is Eric Schaefer?

Eric Schaefer is 40, he's been the Chief Accounting Officer y Vice President of Pacific Biosciences of California Inc since 2020. There are 18 older and no younger executives at Pacific Biosciences of California Inc. The oldest executive at Pacific Biosciences of California Inc is Lucy Shapiro, 79, who is the Independent Director.

What's Eric Schaefer's mailing address?

Eric's mailing address filed with the SEC is PACIFIC BIOSCIENCES OF CALIFORNIA, INC., 1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025.

Insiders trading at Pacific Biosciences of California Inc

Over the last 14 years, insiders at Pacific Biosciences of California Inc have traded over $95,441,111 worth of Pacific Biosciences of California Inc stock and bought 2,252,330 units worth $6,097,136 . The most active insiders traders include Michael Hunkapiller, John F Milligan y Christian O Henry. On average, Pacific Biosciences of California Inc executives and independent directors trade stock every 44 days with the average trade being worth of $202,112. The most recent stock trade was executed by Jeff Eidel on 19 August 2024, trading 26,760 units of PACB stock currently worth $42,548.

What does Pacific Biosciences of California Inc do?

pacbio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. we provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges. our strength comes from the dedication of our people, who are fueled by a desire to effect real, positive change. with a focus on the future and an experienced, passionate team, we are motivated to continue to redefine what is possible in genomics.

Complete history of Mr. Schaefer stock trades at Pacific Biosciences of California Inc

Pacific Biosciences of California Inc executives and stock owners

Pacific Biosciences of California Inc executives and other stock owners filed with the SEC include:

• Michael Hunkapiller,
  Director
• Christian O. Henry M.B.A.,
  Pres, CEO & Director
• Susan G. Kim,
  Chief Financial Officer
• Dr. Denis Zaccarin Ph.D.,
  Sr. VP of R&D
• William Ericson,
  Independent Director
• Randall Livingston,
  Independent Director
• Marshall Mohr,
  Independent Director
• John Milligan,
  Independent Chairman of the Board
• Lucy Shapiro,
  Independent Director
• Kathy Ordonez,
  Director
• Christian Henry,
  President, Chief Executive Officer, Director
• David Botstein,
  Independent Director
• Susan Kim,
  Chief Principal Officer, Chief Accounting Officer
• Eric Schaefer,
  Chief Accounting Officer, Vice President
• Denis Zaccarin,
  Vice President - Semiconductor Integration Devices
• Chris Seipert,
  Vice President, Sales, Service & Support, EMEA and America
• Kathleen Lynch J.D.,
  Head of Global Gov. Affairs & Corp. Communications
• Michele Farmer CPA,
  VP & Chief Accounting Officer
• Kathleen Lynch,
  Head of Global Gov. Affairs & Corp. Communications
• Brett Atkins J.D., Ph.D.,
  Gen. Counsel & Corp. Sec.
• Trevin Rard,
  Head of Investor Relations
• Dr. Jonas Korlach Ph.D.,
  Chief Scientific Officer
• Michele Farmer,
  VP & Chief Accounting Officer
• Mark Van Oene,
  Chief Operating Officer
• Dr. Stephen Turner,
  Co-Founder & CTO
• James Michael Phillips,
  SVP, Research & Development
• Susan K Barnes,
  EVP, CFO and PAO
• Kevin P Corcoran,
  SVP, Market Development
• Brook H Byers,
  Director
• Jeff Eidel,
  See Remarks
• Brian B Dow,
  VP and PAO
• Michael Glynn,
  Chief Commercial Officer
• David B Singer,
  Director
• Susan E Siegel,
  Director
• Hugh C Martin,
  Chairman, CEO & President
• Stephen W Turner,
  VP & Chief Technology Officer
• Hannah Valantine,
  Director
• Oene Mark Van,
  See Remarks
• Peter Fromen,
  See Remarks
• Michele Farmer,
  See Remarks
• David W Meline,
  Director